the aid library

LIST OPTIONS

Filter

2877

Sort by:

Direction:

Download (292)

View PDF (1755)

ProMED

International Society for Infectious Diseases (2015) CC

ProMED - the Program for Monitoring Emerging Diseases - is an Internet-based reporting system dedicated to rapid global dissemination of information on outbreaks of infectious diseases and acute exposures to toxins that affect human health, including those in animals and in plants grown for food or... more

Download (174)

View PDF (1280)

Isoniazid Preventive Therapy and Risk for Resistant Tuberculosis

M. E. Balcells, S. L. Thomas, P. Godfrey-Faussett, et al. (2006) C_CDC

Research Emerging Infectious Diseases Vol. 12, No. 5, May 2006

Download (139)

View PDF (1200)

Vitamin D Deficiency and Tuberculosis Progression

N. Talat, S. Perry, J. Personnet, et al. (2010) C_CDC

Emerging Infectious Diseases Vol. 16, No. 5, May 2010

Download (317)

View PDF (578)

Epidemiology of Primary Multidrug-Resistant Tuberculosis, Vladimir Region, Russia

J. V. Ershova, G. V. Volchenkov, D. A. Kaminski, et al. Centers for Disease Control and Prevention (2015) C_CDC

Emerging Infectious Diseases; Vol. 21, No. 11, November 2015

Download (112)

View PDF (202)

Nodding syndrome

Scott F. Dowell, James J. Sejvar, Lul Riek, et al. CDC (2013) CC

Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 19, No. 9, September 2013

Download (502)

View PDF (606)

Ede Kontwole Marengwen ki Simaye Viris Lafyèv Deng, Chikoungounya, ak Zika

National Center for Emerging and Zoonotic Infectious Diseases Division of Vector-Borne Diseases (CDC) (2015) CC

Download (270)

View PDF (567)

Ayude a controlar los mosquitos que transmiten los virus del dengue, chikungunya y Zika

National Center for Emerging and Zoonotic Infectious Diseases Division of Vector-Borne Diseases (CDC) (2015) CC

Download (301)

View PDF (556)

Contribuez à contrôler les moustiques qui transmettent la dengue, le chikungunya et le Zika

National Center for Emerging and Zoonotic Infectious Diseases Division of Vector-Borne Diseases (CDC) (2015) CC

Download (312)

View PDF (624)

Ajude a controlar os mosquitos que transmitem os vírus da dengue, chikungunya e zika

National Center for Emerging and Zoonotic Infectious Diseases Division of Vector-Borne Diseases (CDC) (2015) CC

Download (348)

View PDF (733)

Pandemic and epidemic-prone diseases

World Health Organization WHO (2017) C_WHO

The past two decades have witnessed changes in how humans live. Travel and trade, rapid urbanization, limited access to health care as well as environmental degradation and other trends all create the conditions for epidemics to thrive and grow. At the same time, the science and knowledge around inf... more

Download (121)

View PDF (831)

Philippine Action Plan to Combat AMR: One Health Approach

Phillipine Department of Health (2019) C_WHO

Antibiotics have been useful in fighting infectious diseases in our country for decades, but because of the overuse and misuse of these agents, an increasing number of organisms are now resistant to them. The Philippines, like other Southeast Asian countries, has already been encountering the many c... more

Download (87)

View PDF (165)

Global Epidemiology of Buruli Ulcer, 2010–2017, and Analysis of 2014 WHO Programmatic Targets

Omansen, T.F.; A. Erbowor-Becksen, R. Yotsu, et al. Emerging Infectious Diseases (EID) Journal (2019) C_CDC

Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 25, No. 12, December 2019 2183 Buruli ulcer is a neglected tropical disease caused by Myocobacterium ulcerans; it manifests as a skin lesion, nodule, or ulcer that can be extensive and disabling. To assess the global burden and the progress ... more

Download (170)

View PDF (151)

Guidelines on Clinical Management of Chikungunya Fever

World Health Organization (WHO), Regional Office for South-East Asia (2007) C_WHO

The socioeconomic factors and public health inadequacies that facilitated the rapid spread of this infection continue to exist. As it is a new and emerging disease it has not received sufficient coverage yet in the medical curricula of Member States. Specific treatment is not available, and there is... more

Download (71)

View PDF (122)

Chagas Disease: From Discovery to a Worldwide Health Problem

Lidani, K.; Andrade, F.; Bavia, L. et al. Frontiers Public Health (2019) CC

Carlos Chagas discovered American trypanosomiasis, also named Chagas disease (CD) in his honor, just over a century ago. He described the clinical aspects of the disease, characterized by its etiological agent (Trypanosoma cruzi) and identified its insect vector. Initially, CD occurred only in Latin... more

Download (86)

View PDF (602)

New Drugs for Human African Trypanosomiasis: A Twenty First Century Success Story

Dickie, E.A.; Giordani, F.; Gould, M.K.; Mäser, P.; Burri, C.; Mottram, J.C.; Rao, S.P.S.; Barrett, M.P. MDPI Tropical Medicine and Infectious Disease (2020) CC2

The twentieth century ended with human African trypanosomiasis (HAT) epidemics raging across many parts of Africa. Resistance to existing drugs was emerging, and many programs aiming to contain the disease had ground to a halt, given previous success against HAT and the competing priorities associat... more

Download (118)

View PDF (433)

Recent Trends in Leishmania Research: A Therapeutic Perspective

Jawed, J. & Majumdar, S. Journal of Infectiology and Epidemiology (2018) CC

Leishmaniasis is a spectrum of disease caused by the infection of protozoan parasite Leishmania mainly affecting the antigen presenting cell of the host. The disease is although considered as neglected tropical disease still it is not completely eradicated. Majority of the issues related to the ther... more

Download (72)

View PDF (312)

Community-Based Interventions for the Prevention and Control of Cutaneous Leishmaniasis

Polidano, K.; Wenning, B.; Ruiz-Cadavid. et al Multidisciplinary Digital Publishing Institute MDPI (2022) CC

Cutaneous leishmaniasis (CL) is a parasitic disease caused by infection with a vector-borne protozoan parasite of the genus Leishmania spp. The parasite is transmitted by the bite of an infected phlebotomine sand fly. Infection results in skin lesions which take a long time to heal and may leave per... more

Download (81)

View PDF (88)

Abuja Declaration on HIV/AIDS, Tuberculosis, and Other Infectious Diseases

African Union (AU) African Union (AU) (2001) CC

The Abuja declaration identifies that the prevention and control of HIV/AIDS, tuberculosis and related infectious diseases must come with additional financial resources. Therefore, African governments agreed on setting the target of allocating at least 15 per cent of each country’s annual budget ... more

Download (99)

View PDF (98)

The urgency of now - Turning the tide against epidemic and pandemic infectious diseases

Coalition for Epidemic Preparedness Innovations (CEPI) Coalition for Epidemic Preparedness Innovations (CEPI) (2021) CC

CEPI is seeking to raise $3.5 billion to implement CEPI’s next 5-year plan. To mitigate the immediate threat of COVID-19 variants, it is activating key elements of this plan now—and seeking to mobilise a portion of this $3.5 billion in 2021. We have already launched R&D programmes to initiate de... more

Download (3)

View PDF (2)

Mpox Testing Strategy - November 2024

Africa Center for Disease Control and Prevention (2024) CC

Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...d in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries. In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response. As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa. more